SCHEMBL1879537

SCHEMBL1879537

O=S(=O)(O)Oc1cccc(O)c1O

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.50
ALDH1A1 P00352 2/20 0.50
HPGD P15428 2/20 0.50
ALOX15 P16050 2/20 0.50
HSD17B10 Q99714 2/20 0.50
TP53 P04637 2/20 0.50
KDM4E B2RXH2 2/20 0.50
ALOX12 P18054 2/20 0.50
MAPT P10636 2/20 0.50
CYP3A4 P08684 1/20 0.50
MAPK1 P28482 1/20 0.50
CA1 P00915 3/20 0.46
CA2 P00918 2/20 0.46
CDK2 P24941 2/20 0.46
ADAMTS4 O75173 1/20 0.46
EGFR P00533 1/20 0.46
FYN P06241 1/20 0.46
MMP2 P08253 1/20 0.46
MMP9 P14780 1/20 0.46
MMP8 P22894 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Naphthalene SCHEMBL27698306 0.92 FABP1 (0.49) LMNAALDH1A1HPGDALOX15HSD17B10
SCHEMBL235067 0.84 HSD11B1 (0.50) LMNAALDH1A1HPGDALOX15HSD17B10
SCHEMBL29382842 0.84 HSD11B1 (0.50) LMNAALDH1A1HPGDALOX15HSD17B10
SCHEMBL3698749 0.84 ALDH1A1 (0.44) LMNAALDH1A1HPGDALOX15HSD17B10
SCHEMBL1890372 0.83 FABP1 (0.41) LMNAALDH1A1HPGDALOX15HSD17B10
SCHEMBL9541027 0.83 HSD11B1 (0.49) LMNAALDH1A1HPGDALOX15HSD17B10
Ammonia Solution, Strong SCHEMBL11405643 0.83 HSD11B1 (0.49) LMNAALDH1A1HPGDALOX15HSD17B10
SCHEMBL18396653 0.82 MAPT (0.55) LMNAALDH1A1HPGDALOX15HSD17B10
SCHEMBL17157291 0.82 ALDH1A1 (0.48) LMNAALDH1A1HPGDALOX15HSD17B10
SCHEMBL31578815 0.82 MAPT (0.55) LMNAALDH1A1HPGDALOX15HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 78 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025123045-A1 PREDICTIVE AND DIAGNOSTIC SCREENING METHODS FOR ENDOMETRIAL CANCER ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF ARIZONA (US) 2025-06-12 WO claimed
US-20200138894-A1 FLAVONOID COMPOSITIONS AND METHODS OF USE BERKLEY, LLC 2020-05-07 US claimed
US-10441621-B2 Flavonoid compositions and methods of use REOXCYN, LLC (US) 2019-10-15 US claimed
US-20170106036-A1 FLAVONOID COMPOSITIONS AND METHODS OF USE BERKLEY, LLC 2017-04-20 US claimed
JP-4717881-B2 2011-07-06 JP claimed
US-7754273-B2 Method of printing a time-temperature indicator based on azo coupling reactions onto a susbtrate CIBA SPECIALTY CHEMICALS CORP. (US) 2010-07-13 US claimed
US-20070218206-A1 Method of Printing a Time-Temperature Indicator Based on Azo Coupling Reactions onto a Susbtrate CIBA SPECIALTY CHEMICALS CORP. 2007-09-20 US claimed
EP-1779104-A1 METHOD OF PRINTING A TIME-TEMPERATURE INDICATOR BASED ON AZO COUPLING REACTIONS ONTO A SUBSTRATE Ciba SC Holding AG (CH) 2007-05-02 EP claimed
WO-2006015962-A1 METHOD OF PRINTING A TIME-TEMPERATURE INDICATOR BASED ON AZO COUPLING REACTIONS ONTO A SUBSTRATE CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) 2006-02-16 WO claimed
EP-0227931-B1 A METHOD FOR PRODUCING CYCLOALKANOLS SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1991-09-11 EP claimed
US-4691064-A CATALYST OF AROMATIC SULFONIC ACID HAVING AT LEAST ONE HYDROXYL OR ETHER GROUP SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1987-09-01 US claimed
EP-0227931-A2 A method for producing cycloalkanols SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1987-07-08 EP claimed
US-12584924-B2 Compositions and methods for diagnosing and treating chronic kidney disease SOCIETE DES PRODUITS NESTLE S.A. (CH) 2026-03-24 US disclosed
WO-2025123045-A1 PREDICTIVE AND DIAGNOSTIC SCREENING METHODS FOR ENDOMETRIAL CANCER ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF ARIZONA (US) 2025-06-12 WO disclosed
US-20250147230-A1 OPTICAL FIBER AND METHOD FOR MANUFACTURING OPTICAL FIBER FURUKAWA ELECTRIC CO., LTD. (JP) 2025-05-08 US disclosed
US-12274730-B2 Flavonoid compositions and methods of use BERKLEY, LLC (US) 2025-04-15 US disclosed
EP-0510442-A1 Substituted 1-sulfonyloxy-2-pyridones, process for their preparation and their use HOECHST AKTIENGESELLSCHAFT (DE) 1992-10-28 EP disclosed
EP-0227931-B1 A METHOD FOR PRODUCING CYCLOALKANOLS SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1991-09-11 EP disclosed
US-4691064-A CATALYST OF AROMATIC SULFONIC ACID HAVING AT LEAST ONE HYDROXYL OR ETHER GROUP SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1987-09-01 US disclosed
EP-0227931-A2 A method for producing cycloalkanols SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1987-07-08 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12584924-B2 Compositions and methods for diagnosing and treating chronic kidney disease GLS, AADAT, FGF23 LMNA 1592/4885ALDH1A1 822/4885HPGD 1669/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.